About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 137 record(s)
Req # A-2020-001263
Adverse Reaction Reports (AERs). Report numbers: E2B_02572215, E2B_02572274, E2B_02573480, E2B_02573878, E2B_02574042, E2B_02574051, E2B_02574070, E2B_02574081, E2B_02574245, E2B_02575806, E2B_02575845, E2B_02576316, E2B_02577400, E2B_02577679, E2B_02578124, E2B_02578137, E2B_02579039, E2B_02579242, E2B_02579877, E2B_02580433.Organization: Health Canada
July 2021
Req # A-2020-001523
Adverse Reaction Reports (AERs). Report numbers: E2B_03034443, E2B_03035076, E2B_03036291, E2B_03036318, E2B_03036563, E2B_03037091, E2B_03037543, E2B_03037703, E2B_03037709, E2B_03038359, E2B_03039862, E2B_03040094, E2B_03040194, E2B_03041363, E2B_03041626, E2B_03042614, E2B_03042685, E2B_03042723, E2B_03042764, E2B_03043134.Organization: Health Canada
July 2021
Req # A-2020-001552
Adverse Reaction Reports (AERs) for METRONIDAZOLE. Report numbers: 737155, E2B_03168356, E2B_03068937, E2B_03140445, E2B_03021814.Organization: Health Canada
July 2021
Req # A-2020-001563
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-115518-128.Organization: Health Canada
July 2021
Req # A-2020-001657
Adverse Reaction Reports (AERs) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_03248594, E2B_03249055, E2B_03252308, E2B_03253381, E2B_03254495, E2B_03257097, E2B_03260223, E2B_03260976, E2B_03266535, E2B_03266843, E2B_03266953, E2B_03268369, E2B_03273459, E2B_03276072, E2B_03277351, E2B_03256775.Organization: Health Canada
July 2021
Req # A-2020-001685
Adverse Reaction Reports (AERs). Report numbers: E2B_03315793, E2B_03396257, E2B_03397736, E2B_03397787, E2B_03282877, E2B_02353302, E2B_03324272, E2B_03402662, E2B_03279197.Organization: Health Canada
July 2021
Req # A-2020-001746
Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03320875.Organization: Health Canada
July 2021
Req # A-2020-001832
Adverse Reaction Reports (AERs). Report numbers: E2B_03426776, 000924311, E2B_03437489, E2B_03508059, E2B_03326229, E2B_03488964, E2B_03423191, 000736893, 000916101.Organization: Health Canada
July 2021
Req # A-2020-001885
Adverse Reaction Reports (AERs) for Mesalazine. Report numbers: E2B_03460490, E2B_03495844, 928718, E2B_03406701, E2B_03453475, E2B_03485142, E2B_03421636, E2B_03496420, 927137, 924338, 927129.Organization: Health Canada
July 2021
Req # A-2020-001895
Adverse Reaction Reports (AERs) for Mezavant. Report numbers: E2B_03321791, 919523, 924749, E2B_03284156, E2B_03286468, E2B_03292641, E2B_03302640. (ADRs) for Vyvanse. Report numbers: E2B_03300503, E2B_03287086, E2B_03284951. (ADR) for C1 Esterase Inhibitor (Human). Report number: E2B_03287283. (ADRs) for Immunoglobulin (human). Report numbers: E2B_03320951, E2B_03299907, E2B_03286704.Organization: Health Canada
July 2021